Tylolide Granules for Oral Solution 100% ww

País: Malásia

Língua: inglês

Origem: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Compre agora

Ingredientes ativos:

Tylosin (as tartrate)

Disponível em:

Weissen Company (m) Sdn. Bhd.

DCI (Denominação Comum Internacional):

Tylosin (as tartrate)

Fabricado por:

Laboratoires BIOVE

Características técnicas

                                PACKAGE INSERT
Brand or product name
Tylolide Granules for Oral Solution 100 % w/w
Name and Strength of
Active Substance/
Preservative(s)
Composition per tub:
Tylosin (as tartrate)…………….100,000,000 IU
(Equivalent to 100 g of tylosin per tub or equivalent to 110 g of
tylosin
tartrate per tub)
Product Description
Almost white to light yellow granules
Pharmacodynamics
Tylosin is a macrolide antibiotic produced by a strain of
_Streptomyces _
_fradiae._ It exerts its antimicrobial effect by inhibiting protein
synthesis
of susceptible micro-organisms.
The
tylosin
spectrum
of
activity
includes
amongst
others
Gram-
positive bacteria, some Gram – negative strains such as _
Pasteurella_,
and _Mycoplasma spp_.
Pharmacokinetics
In most species peak plasma concentrations have been attained 1 to 2
hours
after
administration
of
tylosin.
Compared
to
plasma
levels
clearly higher tissue concentrations have been observed. Tylosin was
extensively metabolised.
Environmental
Properties
Most of the residues are excreted in faeces predominantly consisting
of
tylosin (factor A), relomycin (factor D) and dihydrodesmycosin.
Indication
Calves:
Treatment
and
prevention
of
pneumonia
caused
by
_Mycoplasma spp _when the disease has been established in the herd.
Pigs: Treatment and prevention of enzootic pneumonia caused
by
_Mycoplasma _
_hyopneumoniae_
and
_Mycoplasma _
_hyorhinis _
when
the
disease has been established in the herd.
Treatment and prevention of Porcine Intestinal Adenomatosis (Ileitis)
associated with _ Lawsonia intracellularis _ when the disease has been
established in the herd.
Chickens: Treatment and prevention of chronic respiratory diseases
(CRD)
caused
by
_Mycoplasma _
_gallisepticum_
and
_Mycoplasma _
_synoviae _when the disease has been established in the flock.
Treatment and prevention of necrotic enteritis caused by _ Clostridium
_
_perfringens_ when the disease has been established in the flock.
_ _
Turkeys: Treatment and prevention of infectious sinusitis caused by
_Mycoplasma gallisepticum _ when the dis
                                
                                Leia o documento completo
                                
                            

Pesquisar alertas relacionados a este produto